Skip to main content
OpenTrials
Completed

NCT Number: NCT01176448

Laser Resurfacing Versus Dermabrasion for Scar Revision

Dermabrasion has been the historical standard used for resurfacing scars on the skin. Recently, fractionated laser therapy has been FDA approved for scar resurfacing. This study intends to compare dermabrasion versus fractionated laser therapy for scar resurfacing.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cicatrix Cardiovascular Diseases Coagulation, Laser Dermabrasion Embolism and Thrombosis Fibrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Thrombosis Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Zel Skin and Laser

Edina, Minnesota, 55424, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Post-surgical or post traumatic scar on face or scalp.
  • Age 18 or older
  • Able to read and comprehend English
  • Willing to follow treatment schedule and post treatment care requirements
  • Signed the informed consent form
  • Fitzpatrick skin type I-III

Exclusion criteria

  • known photosensitivity
  • Taken any medications known to induce photosensitivity in previous three months
  • Taken Accutane within past 12 months
  • Pregnant or nursing
  • Currently on topical or oral antibiotics
  • Immunocompromised status
  • Skin type IV or greater

Treatment and study plan

Fractionated laser

Device

Fractionated laser in the form of the Re:Pair CO2 laser manufactured by Solta Medical.

Dermabrasion

Device

Diamond Fraise Dermabrasion will be performed in standard fashion down to papillary dermis.

Primary outcomes

  1. Safey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After Resurfacing

    Time frame: Day 0, Week1, Month 1

    Erythema, edema, bleeding, and eschar after resurfacing were used as indicators of safety. Each was judged based on a 4 point ordinal scale 0=absent, 1=mild, 2=moderate, 3=severe.

Secondary outcomes

  1. Visual Analog Scale for Assessing Scar Improvement.

    Time frame: 3 months

    Visual Analog Scale for assessing scar improvement. 0 : Worsening or no improvement

    • : 1-25% improvement
    • : 26-50% improvement
    • : 51-75% improvement
    • : 76-100% improvement

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Official study title

A Comparison Evaluation of Fractional Laser Therapy and Dermabrasion for Scar Revision

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Aug 6, 2010
Registry last updated
Nov 1, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.